Aleks Engel | Director, REPAIR Impact Fund
Novo Holdings

Aleks Engel, Director, REPAIR Impact Fund, Novo Holdings

Aleks Engel is a partner with Novo Holdings where he has worked for 10 years.  He is the Director of the REPAIR Impact Fund, a founding board member of the AMR Action Fund, and a board member of Paratek Pharmaceuticals, a commercial anti-infectives company.  Aleks is based in Boston

Appearances:



Day 2 - World Antimicrobial Resistance Congress & Disease Prevention Control Summit 2024 @ 11:00

Investors panel: Seeking returns from investing in anti-infectives

Panel of investors in AMR will discuss deal dynamics and areas of particular interest.

last published: 14/Nov/24 16:45 GMT
last published: 14/Nov/24 16:45 GMT

back to speakers